Reported updated data from ongoing Phase b trial in kidney transplantation demonstrating tegoprubart treatment successfully prevented kidney transplant rejection and was generally safe and well-tolerated Dosed first participants in Phase BESTOW trial in kidney transplantation Tegoprubart dosed in second-ever pig to human xenotransplant procedure IRVINE Calif Jan GLOBE NEWSWIRE -- Eledon Pharmaceuticals Inc Eledon NASDAQ ELDN today announced a summary...
Globe News Wire
Global Antivenom Market Global Antivenom Market Dublin Jan GLOBE NEWSWIRE -- The Antivenom Global Market Report report has been added to ResearchAndMarkets com's offering Antivenom also known as antivenin is an antibody therapy that can block the poisons inside a specific venom if injected soon after a bite It is generally used to treat poisonous animal bites or stings such...
Company Also Announces Departure of Angelo Scopelianos Ph D ALACHUA Fla and TAMPA Fla Jan GLOBE NEWSWIRE -- Axogen Inc NASDAQ AXGN a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries today announced the promotions of three research and development team members The promotions are Erick DeVinney to Chief Innovation Officer Mr DeVinney joined Axogen...
NEW YORK Jan GLOBE NEWSWIRE -- The law firm of Kirby McInerney LLP is investigating potential claims against Amylyx Pharmaceuticals Inc Amylyx or the Company NASDAQ AMLX The investigation concerns whether Amylyx and or certain of its officers have violated the federal securities laws and or engaged in other unlawful business practices On November Amylyx issued a press release announcing...